INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $85,705 | -56.0% | 25,060 | -32.4% | 0.00% | 0.0% |
| Q1 2016 | $195,000 | -33.0% | 37,083 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $291,000 | -3.6% | 37,083 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $302,000 | -23.9% | 35,720 | -1.4% | 0.00% | -33.3% |
| Q2 2015 | $397,000 | -26.8% | 36,229 | -6.5% | 0.00% | -25.0% |
| Q1 2015 | $542,000 | -17.1% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $654,000 | +25.8% | 38,742 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $520,000 | +5.3% | 38,742 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $494,000 | +7.2% | 38,742 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $461,000 | -13.8% | 38,742 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $535,000 | -20.9% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $676,000 | +7.3% | 38,742 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $630,000 | – | 38,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |